AAPL   382.07 (-0.17%)
MSFT   212.94 (-0.64%)
FB   241.95 (-1.04%)
GOOGL   1,519.00 (+0.02%)
AMZN   3,186.77 (+0.13%)
CGC   16.81 (+4.93%)
MU   50.35 (+0.74%)
GE   6.68 (+1.52%)
TSLA   1,408.30 (+1.01%)
T   29.86 (+1.08%)
DIS   119.11 (+1.96%)
NFLX   531.14 (+4.60%)
BA   175.76 (+1.43%)
AAPL   382.07 (-0.17%)
MSFT   212.94 (-0.64%)
FB   241.95 (-1.04%)
GOOGL   1,519.00 (+0.02%)
AMZN   3,186.77 (+0.13%)
CGC   16.81 (+4.93%)
MU   50.35 (+0.74%)
GE   6.68 (+1.52%)
TSLA   1,408.30 (+1.01%)
T   29.86 (+1.08%)
DIS   119.11 (+1.96%)
NFLX   531.14 (+4.60%)
BA   175.76 (+1.43%)
AAPL   382.07 (-0.17%)
MSFT   212.94 (-0.64%)
FB   241.95 (-1.04%)
GOOGL   1,519.00 (+0.02%)
AMZN   3,186.77 (+0.13%)
CGC   16.81 (+4.93%)
MU   50.35 (+0.74%)
GE   6.68 (+1.52%)
TSLA   1,408.30 (+1.01%)
T   29.86 (+1.08%)
DIS   119.11 (+1.96%)
NFLX   531.14 (+4.60%)
BA   175.76 (+1.43%)
AAPL   382.07 (-0.17%)
MSFT   212.94 (-0.64%)
FB   241.95 (-1.04%)
GOOGL   1,519.00 (+0.02%)
AMZN   3,186.77 (+0.13%)
CGC   16.81 (+4.93%)
MU   50.35 (+0.74%)
GE   6.68 (+1.52%)
TSLA   1,408.30 (+1.01%)
T   29.86 (+1.08%)
DIS   119.11 (+1.96%)
NFLX   531.14 (+4.60%)
BA   175.76 (+1.43%)
Log in

NASDAQ:OFIXOrthofix Medical Stock Price, Forecast & News

$30.06
+0.38 (+1.28 %)
(As of 07/10/2020 12:10 PM ET)
Add
Compare
Today's Range
$29.46
Now: $30.06
$30.06
50-Day Range
$29.87
MA: $33.71
$38.15
52-Week Range
$22.11
Now: $30.06
$55.17
Volume1,116 shs
Average Volume122,137 shs
Market Capitalization$577.15 million
P/E RatioN/A
Dividend YieldN/A
Beta0.99
Orthofix Medical Inc., a medical device company, provides musculoskeletal healing products and therapies worldwide. It operates through four segments: Bone Growth Therapies, Spinal Implants, Biologics, and Orthofix Extremities. The Bone Growth Therapies segment manufactures, distributes, and provides support services for bone growth stimulator devices that enhance bone fusion and are indicated as treatment to enhance fusion success rates in cervical and lumbar spine, as well as a therapeutic treatment for non-spinal appendicular fractures. The Spinal Implants segment designs, develops, and markets a portfolio of implant products used in surgical procedures of the spine. The Biologics segment provides a portfolio of regenerative products and tissue forms that allow physicians to treat a range of spinal and orthopedic conditions. The Orthofix Extremities segment designs, develops, and markets orthopedic products used in fracture repair, deformity correction, and bone reconstruction procedures. The company markets and distributes its products through direct sales representatives; independent distributors; and employed and independent sales representatives to physicians, hospitals, ambulatory surgery centers, integrated health delivery systems, and other purchasing organizations. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1987 and is headquartered in Lewisville, Texas.
Read More
Orthofix Medical logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.3Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.44 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
Current SymbolNASDAQ:OFIX
CUSIPN6748L10
Phone214-937-2000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$459.95 million
Cash Flow$2.96 per share
Book Value$17.22 per share

Profitability

Net Income$-28,460,000.00

Miscellaneous

Employees1,055
Market Cap$577.15 million
Next Earnings Date8/3/2020 (Estimated)
OptionableOptionable

Receive OFIX News and Ratings via Email

Sign-up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.

Orthofix Medical (NASDAQ:OFIX) Frequently Asked Questions

How has Orthofix Medical's stock been impacted by COVID-19 (Coronavirus)?

Orthofix Medical's stock was trading at $30.67 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, OFIX shares have decreased by 2.0% and is now trading at $30.06. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Orthofix Medical?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthofix Medical in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Orthofix Medical.

When is Orthofix Medical's next earnings date?

Orthofix Medical is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Orthofix Medical.

How were Orthofix Medical's earnings last quarter?

Orthofix Medical Inc (NASDAQ:OFIX) announced its quarterly earnings data on Friday, May, 8th. The medical device company reported $0.09 EPS for the quarter, missing the consensus estimate of $0.11 by $0.02. The medical device company earned $104.82 million during the quarter, compared to the consensus estimate of $104.50 million. Orthofix Medical had a positive return on equity of 7.46% and a negative net margin of 0.81%. View Orthofix Medical's earnings history.

What price target have analysts set for OFIX?

2 Wall Street analysts have issued 1 year price objectives for Orthofix Medical's stock. Their forecasts range from $42.00 to $56.00. On average, they anticipate Orthofix Medical's share price to reach $49.00 in the next year. This suggests a possible upside of 63.0% from the stock's current price. View analysts' price targets for Orthofix Medical.

Has Orthofix Medical been receiving favorable news coverage?

Headlines about OFIX stock have trended somewhat positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthofix Medical earned a news sentiment score of 1.2 on InfoTrie's scale. They also gave headlines about the medical device company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View the latest news about Orthofix Medical.

Are investors shorting Orthofix Medical?

Orthofix Medical saw a decline in short interest in June. As of June 30th, there was short interest totaling 321,700 shares, a decline of 9.4% from the June 15th total of 355,200 shares. Based on an average daily trading volume, of 165,400 shares, the short-interest ratio is presently 1.9 days. Currently, 1.7% of the shares of the company are sold short. View Orthofix Medical's Current Options Chain.

Who are some of Orthofix Medical's key competitors?

What other stocks do shareholders of Orthofix Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Orthofix Medical investors own include AbbVie (ABBV), Enterprise Products Partners (EPD), Gilead Sciences (GILD), Exxon Mobil (XOM), Allergan (AGN), Biogen (BIIB), Clovis Oncology (CLVS), Esperion Therapeutics (ESPR), Edwards Lifesciences (EW) and Intercept Pharmaceuticals (ICPT).

Who are Orthofix Medical's key executives?

Orthofix Medical's management team includes the following people:
  • Mr. Bradley R. Mason, Pres, CEO & Director (Age 65)
  • Mr. Douglas C. Rice, CFO & Chief Accounting Officer (Age 53)
  • Ms. Kimberley A. Elting, Chief Legal & Admin. Officer (Age 54)
  • Mr. Michael M. Finegan, Chief Strategy Officer (Age 55)
  • Mr. Davide Bianchi, Pres of Global Extremities (Age 54)

What is Orthofix Medical's stock symbol?

Orthofix Medical trades on the NASDAQ under the ticker symbol "OFIX."

Who are Orthofix Medical's major shareholders?

Orthofix Medical's stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Dalton Greiner Hartman Maher & Co. (0.25%). Company insiders that own Orthofix Medical stock include Brad Mason, Bradley V Niemann, Davide Bianchi, James F Hinrichs, Jon Carl Serbousek, Kimberley A Elting, Luke T Faulstick, Rice Doug and Ronald A Matricaria. View institutional ownership trends for Orthofix Medical.

Which major investors are selling Orthofix Medical stock?

OFIX stock was sold by a variety of institutional investors in the last quarter, including Dalton Greiner Hartman Maher & Co.. View insider buying and selling activity for Orthofix Medical.

How do I buy shares of Orthofix Medical?

Shares of OFIX can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Orthofix Medical's stock price today?

One share of OFIX stock can currently be purchased for approximately $30.06.

How big of a company is Orthofix Medical?

Orthofix Medical has a market capitalization of $577.15 million and generates $459.95 million in revenue each year. The medical device company earns $-28,460,000.00 in net income (profit) each year or $1.47 on an earnings per share basis. Orthofix Medical employs 1,055 workers across the globe.

What is Orthofix Medical's official website?

The official website for Orthofix Medical is www.orthofix.com.

How can I contact Orthofix Medical?

Orthofix Medical's mailing address is 3451 Plano Parkway, Lewisville TX, 75056. The medical device company can be reached via phone at 214-937-2000 or via email at [email protected]

This page was last updated on 7/10/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.